Refine by MP, party, committee, province, or result type.

Results 1-5 of 5

Finance committee  Definitely. Thank you for raising the question. With rare diseases, it is something that would be wonderful to include within pharmacare. I think that is everyone's vision going forward, recognizing, of course, that we might need to have a bit of a separate strategy in terms of

February 3rd, 2020Committee meeting

Dr. Melanie Bechard

Finance committee  Perfect. Thank you very much for the question. I think no one will be surprised when I say it's critically important that we get movement in this year's budget. As some folks might already be aware, in the 2019 budget there was some funding for a Canadian drug agency. That has a

February 3rd, 2020Committee meeting

Dr. Melanie Bechard

Finance committee  I think it's an excellent question. Truly it benefits society at multiple levels: of course, the end-users, the patients, each of us who will be taking prescription medication in order to stay healthy. I think businesses, particularly small businesses, are often forgotten when w

February 3rd, 2020Committee meeting

Dr. Melanie Bechard

Finance committee  Absolutely. As you're probably aware, the Hoskins report anticipates an average savings of $350 per year for the average Canadian family, and about $700 per employee for Canadian businesses offering private drug plans. That's what we can anticipate at the end-user level, but I

February 3rd, 2020Committee meeting

Dr. Melanie Bechard

Finance committee  Thank you to the members of the Standing Committee on Finance for the invitation to speak today. I'm here not only as an executive board member of Canadian Doctors for Medicare, but also as a pediatrician currently training to be a pediatric emergency specialist at the Children's

February 3rd, 2020Committee meeting

Dr. Melanie Bechard